Cargando…

Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response

This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandolfi, Marco, Liguori, Alessandro, Gurgitano, Martina, Arrichiello, Antonio, Di Meglio, Letizia, Rodà, Giovanni, Guadagni, Alice, Angileri, Salvatore Alessio, Ierardi, Anna Maria, Paolucci, Aldo, Carrafiello, Gianpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023075/
https://www.ncbi.nlm.nih.gov/pubmed/33245070
http://dx.doi.org/10.23750/abm.v91i10-S.10260
_version_ 1783675056596975616
author Pandolfi, Marco
Liguori, Alessandro
Gurgitano, Martina
Arrichiello, Antonio
Di Meglio, Letizia
Rodà, Giovanni
Guadagni, Alice
Angileri, Salvatore Alessio
Ierardi, Anna Maria
Paolucci, Aldo
Carrafiello, Gianpaolo
author_facet Pandolfi, Marco
Liguori, Alessandro
Gurgitano, Martina
Arrichiello, Antonio
Di Meglio, Letizia
Rodà, Giovanni
Guadagni, Alice
Angileri, Salvatore Alessio
Ierardi, Anna Maria
Paolucci, Aldo
Carrafiello, Gianpaolo
author_sort Pandolfi, Marco
collection PubMed
description This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive therapy and is both safe and effective procedure with low risks and high technical successes, making this procedure as the best alternative to surgery. A lot of technical changes would compromise clinical outcomes after procedure, including a variable prostate vascular anatomy, thin PA, and extensive atherosclerotic disease. The purpose of our study is to exploit the advantages of Perfusion Cone Beam Computed Tomography (CBCT) that could impact treatment and help interventional radiologists for treatment planning, diagnosis and for assessing the technical feasibility during PAE, mitigating the risk of nontarget embolization and suggesting clinical outcomes. Qualitative and quantitative clinical pre- and post-treatment values will be compared, to reach the best possible results. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-8023075
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-80230752021-04-07 Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response Pandolfi, Marco Liguori, Alessandro Gurgitano, Martina Arrichiello, Antonio Di Meglio, Letizia Rodà, Giovanni Guadagni, Alice Angileri, Salvatore Alessio Ierardi, Anna Maria Paolucci, Aldo Carrafiello, Gianpaolo Acta Biomed Original Article This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive therapy and is both safe and effective procedure with low risks and high technical successes, making this procedure as the best alternative to surgery. A lot of technical changes would compromise clinical outcomes after procedure, including a variable prostate vascular anatomy, thin PA, and extensive atherosclerotic disease. The purpose of our study is to exploit the advantages of Perfusion Cone Beam Computed Tomography (CBCT) that could impact treatment and help interventional radiologists for treatment planning, diagnosis and for assessing the technical feasibility during PAE, mitigating the risk of nontarget embolization and suggesting clinical outcomes. Qualitative and quantitative clinical pre- and post-treatment values will be compared, to reach the best possible results. (www.actabiomedica.it) Mattioli 1885 2020 2020-09-23 /pmc/articles/PMC8023075/ /pubmed/33245070 http://dx.doi.org/10.23750/abm.v91i10-S.10260 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Pandolfi, Marco
Liguori, Alessandro
Gurgitano, Martina
Arrichiello, Antonio
Di Meglio, Letizia
Rodà, Giovanni
Guadagni, Alice
Angileri, Salvatore Alessio
Ierardi, Anna Maria
Paolucci, Aldo
Carrafiello, Gianpaolo
Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
title Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
title_full Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
title_fullStr Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
title_full_unstemmed Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
title_short Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
title_sort prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam ct to evaluate planning and treatment response
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023075/
https://www.ncbi.nlm.nih.gov/pubmed/33245070
http://dx.doi.org/10.23750/abm.v91i10-S.10260
work_keys_str_mv AT pandolfimarco prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT liguorialessandro prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT gurgitanomartina prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT arrichielloantonio prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT dimeglioletizia prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT rodagiovanni prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT guadagnialice prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT angilerisalvatorealessio prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT ierardiannamaria prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT paoluccialdo prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse
AT carrafiellogianpaolo prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse